FDA warns of fake gov't warning letters sent to consumers

July 13, 2018 by Matthew Perrone

U.S. health authorities are alerting consumers to a new scam involving fake government warning letters sent to people who tried to buy medicines online or over the phone.

The Food and Drug Administration said Friday that the fake letters may be part of an extortion scam. However, authorities have not yet documented cases of consumers being coerced to turn over money.

The forged letters claim to be from the FDA or the Federal Trade Commission, but those agencies almost never issue such warnings to private individuals, but rather to companies, professionals or industry officials. The letters falsely claim that the government is investigating the drugs the attempted to purchase.

FDA officials have repeatedly warned about the risks of buying medicines through unverified online pharmacies.

Explore further: FDA warns websites marketing unapproved opioids

Related Stories

FDA warns websites marketing unapproved opioids

June 11, 2018
(HealthDay)—Nine online networks, operating 53 websites, have been warned that they must stop illegally marketing potentially dangerous, unapproved, and misbranded versions of opioid medications, according to the U.S. Food ...

FDA issues warning letters to powdered caffeine distributors

September 1, 2015
The Food and Drug Administration has issued warning letters to five distributors of pure powdered caffeine, saying the products put consumers at risk of illness or injury.

Deadline to clear up health law eligibility near

August 12, 2014
The administration is warning hundreds of thousands of consumers they risk losing taxpayer-subsidized health insurance unless they act quickly to resolve issues about their citizenship and immigration status.

FDA seizes counterfeit drugs, devices sold online

June 19, 2015
(HealthDay)—The U.S. Food and Drug Administration, along with international partners, moved this week against more than 1,050 websites that sell potentially dangerous counterfeit medicines and medical devices, the agency ...

Recommended for you

Novel botulinum toxin compound relieves chronic pain

July 18, 2018
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to research by UCL, ...

FDA recalls heart medication valsartan, citing cancer concerns

July 17, 2018
The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.

Opioids given too easily to children: study

July 16, 2018
(HealthDay)—Many children are prescribed powerful opioid painkillers they don't really need, putting them and those around them at risk, a new study shows.

Study reveals opioid patients face multiple barriers to treatment

July 12, 2018
In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Report details possible conflict of interest issues for FDA advisors

July 6, 2018
Charles Piller, a contributing correspondent for the journal Science, has published a Feature piece in the journal detailing what he describes as possible conflicts of interest issues by people who serve as advisors to the ...

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.